Sendai, Japan

Mika Watanabe

This inventor holds 18 USPTO granted patents and 2 published patent applications and 11 EPO patents, primarily in Pathological Diagnosis Support. Top assignee: Konica Minolta, Inc.. Active years: 2015-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mika Watanabe. Retrieved from https://idiyas.com/inventor/mika-watanabe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18 

% Patents Active = 94.4

 

Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2015-2022

Loading Chart...
Loading Chart...
Areas of Expertise:
Tissue Staining
Fluorescent Nanoparticles
Image Processing
Pathological Diagnosis
Biological Substance Detection
Quantitation Method
Medical Image Processor
Storage Medium
Prediction Support
Biological Material Detection
Pathological Complete Response
18 patents (USPTO):Explore Patents

Title: The Innovative Journey of Mika Watanabe

Introduction

Mika Watanabe, an accomplished inventor based in Sendai, Japan, has made significant contributions to the field of biomedical engineering. With a remarkable portfolio of 18 patents, Watanabe's work focuses on advanced methods for tissue analysis and cancer diagnosis. Her innovative approaches aim to enhance the accuracy and efficiency of medical diagnostics.

Latest Patents

Among her latest inventions is a groundbreaking **tissue staining method**. This method enables the simultaneous observation of both tissue morphology and the detection of biological substances, such as antigen molecules, on a single tissue section. The process involves hematoxylin-eosin (HE) staining followed by a histochemical staining technique. This novel approach allows researchers and medical professionals to perform detailed examinations without the need for multiple sections, thus optimizing resource use and improving diagnostic clarity.

Another notable patent from Watanabe is a **test support method for predicting pathological complete response (pCR)** using fluorescent nanoparticles. This innovative method predicts whether a patient undergoing preoperative chemotherapy will achieve a pCR by analyzing breast cancer tissue samples. The process includes acquiring fluorescence images that reveal the expression levels of breast cancer-related proteins, enabling more personalized treatment strategies and potentially improving patient outcomes.

Career Highlights

Mika Watanabe currently works at Konica Minolta, Inc., where she leverages her expertise to drive advancements in medical technology. Her career is marked by a commitment to developing innovative solutions that address critical healthcare challenges. As a female inventor in a predominantly male field, Watanabe serves as an inspiration for aspiring women in technology and science.

Collaborations

Throughout her professional journey, Watanabe has collaborated with esteemed colleagues such as Kohsuke Gonda and Noriaki Ohuchi. These partnerships have fostered an environment of creativity and innovation, leading to the successful development of her patented technologies.

Conclusion

Mika Watanabe's contributions to the field of biomedical engineering are exemplary. Her patents not only enhance diagnostic techniques but also represent a significant step forward in cancer treatment methodologies. Through collaboration and innovation at companies like Konica Minolta, Watanabe continues to pave the way for advancements that promise to benefit healthcare professionals and patients alike.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…